A
Albert J. ten Tije
Researcher at Erasmus University Rotterdam
Publications - 61
Citations - 3092
Albert J. ten Tije is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Population & Hazard ratio. The author has an hindex of 20, co-authored 61 publications receiving 1990 citations. Previous affiliations of Albert J. ten Tije include Erasmus University Medical Center & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Renu R. Bahadoer,Esmée A Dijkstra,Boudewijn van Etten,Corrie A.M. Marijnen,Corrie A.M. Marijnen,Hein Putter,Elma Meershoek-Klein Kranenbarg,Annet G H Roodvoets,Iris D. Nagtegaal,Regina G. H. Beets-Tan,Lennart Blomqvist,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemovic,Andrés Cervantes,Per Nilsson,Bengt Glimelius,Cornelis J.H. van de Velde,Geke A. P. Hospers,L. Østergaard,F. Svendsen Jensen,P. Pfeiffer,K.E.J. Jensen,M.P. Hendriks,W.H. Schreurs,H.P. Knol,J.J. van der Vliet,J.B. Tuynman,A.M.E. Bruynzeel,E.D. Kerver,S. Festen,M E van Leerdam,G.L. Beets,L.G.H. Dewit,C.J.A. Punt,Pieter J. Tanis,E.D. Geijsen,P. Nieboer,W.A. Bleeker,A.J. Ten Tije,R.M.P.H. Crolla,A.C.M. van de Luijtgaarden,J.W.T. Dekker,J.M. Immink,F.J.F. Jeurissen,A.W.K.S. Marinelli,H.M. Ceha,T.C. Stam,P. Quarles an Ufford,W.H. Steup,A.L.T. Imholz,R.J.I. Bosker,J.H.M. Bekker,G.J. Creemers,G.A.P. Nieuwenhuijzen,H. van den Berg,W.M. van der Deure,R.F. Schmitz,J.M. van Rooijen,A.F.T. Olieman,A.C.M. van den Bergh,Derk Jan A. de Groot,Klaas Havenga,Jannet C. Beukema,J. de Boer,P.H.J.M. Veldman,E.J.M. Siemerink,J.W.P. Vanstiphout,B. de Valk,Q.A.J. Eijsbouts,M.B. Polée,C. Hoff,A. Slot,H.W. Kapiteijn,K.C.M.J. Peeters,F.P. Peters,P.A. Nijenhuis,S.A. Radema,H. de Wilt,P. Braam,G.J. Veldhuis,D. Hess,T. Rozema,O. Reerink,D. Ten Bokkel Huinink,A. Pronk,Janet R. Vos,M. Tascilar,G.A. Patijn,C. Kersten,O. Mjåland,M. Grønlie Guren,A.N. Nesbakken,J. Benedik,I. Edhemovic,V. Velenik,J. Capdevila,E. Espin,R. Salazar,S. Biondo,V. Pachón,J. die Trill,J. Aparicio,E. Garcia Granero,M.J. Safont,J.C. Bernal,A. Cervantes,A. Espí Macías,L. Malmberg,G. Svaninger,H. Hörberg,G. Dafnis,A. Berglund,L. Österlund,K. Kovacs,J. Hol,S. Ottosson,G. Carlsson,C. Bratthäll,J. Assarsson,B.L. Lödén,P. Hede,I. Verbiené,O. Hallböök,A. Johnsson,M.L. Lydrup,K. Villmann,P. Matthiessen,J.H. Svensson,J. Haux,S. Skullman,T. Fokstuen,Torbjörn Holm,P. Flygare,M. Walldén,B. Lindh,O. Lundberg,C. Radu,L. Påhlman,A. Piwowar,K. Smedh,U. Palenius,S. Jangmalm,P. Parinkh,H. Kim,M.L. Silviera +147 more
TL;DR: The Rectal cancer And Preoperative Induction therapy followed by Dedicated Operation (RAPIDO) trial aimed to reduce distant metastases without compromising locoregional control.
Journal ArticleDOI
Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.
TL;DR: Kinetic experiments revealed that addition of CrEL to the formulation of oral drug preparations seems to result in significantly diminished drug uptake and reduced circulating concentrations, in contrast to the enhancing effects of Tween® 80.
Journal ArticleDOI
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Linda M. Henricks,Carin A.T.C. Lunenburg,Femke M. de Man,Didier Meulendijks,Geert W.J. Frederix,Emma Kienhuis,Geert Jan Creemers,Arnold Baars,Vincent O. Dezentjé,Alexander L T Imholz,Frank J.F. Jeurissen,Johanna E.A. Portielje,Rob L. H. Jansen,Paul Hamberg,Albert J. ten Tije,Helga J. Droogendijk,Miriam Koopman,Peter Nieboer,Marlène H.W. van de Poel,Caroline M.P.W. Mandigers,Hilde Rosing,Jos H. Beijnen,Jos H. Beijnen,Erik van Werkhoven,André B.P. van Kuilenburg,Ron H.N. van Schaik,Ron H.J. Mathijssen,Jesse J. Swen,Hans Gelderblom,Annemieke Cats,Henk-Jan Guchelaar,Jan H.M. Schellens,Jan H.M. Schellens +32 more
TL;DR: Overall, fluoropyrimidine-related severe toxicity was higher in DPYD variant carriers than in wild-type patients in this prospective, multicentre, safety analysis in 17 hospitals in the Netherlands, and relative risks for severe toxicity were compared between the current study and a historical cohort ofDPYD variant allele carriers treated with full dose fluoropyridine-based therapy.
Journal ArticleDOI
Factors affecting cytochrome P-450 3A activity in cancer patients.
Sharyn D. Baker,Ron H.N. van Schaik,Laurent P. Rivory,Albert J. ten Tije,Kimberly Dinh,Wilfried J. Graveland,Paul W. Schenk,Kellie A. Charles,Stephen Clarke,Michael A. Carducci,William P. McGuire,Fitzroy W. Dawkins,Hans Gelderblom,Jaap Verweij,Alex Sparreboom +14 more
TL;DR: In this article, the authors identify the demographic, physiologic, and inheritable factors that influence CYP3A activity in cancer patients using the erythromycin breath test as a phenotyping probe.
Journal ArticleDOI
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
Maxime J M van der Valk,Corrie A.M. Marijnen,Corrie A.M. Marijnen,Boudewijn van Etten,Esmée A Dijkstra,Denise E. Hilling,Elma Meershoek-Klein Kranenbarg,Hein Putter,Annet G H Roodvoets,Renu R. Bahadoer,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemovic,Andrés Cervantes,Derk Jan A. de Groot,Per Nilsson,Bengt Glimelius,Cornelis J.H. van de Velde,Geke A. P. Hospers +20 more
TL;DR: Although considerable toxicity was observed during preoperative therapy, this did not lead to differences in surgical procedures or postoperative complications, and high compliance of preoperative systemic treatment could be achieved with the experimental approach.